Beth Carter, PhD, MPH, is a senior policy advisor at the AARP Public Policy Institute. Her areas of expertise include epidemiology, public health, disease prevention, and mental health. AARP is a Dissemination and Implementation partner organization to the United States Preventive Services Task Force (USPSTF) and Beth Carter serves as the AARP representative.Read her full biography.
The Centers for Disease Control and Prevention endorsed the use of new vaccines for respiratory syncytial virus (RSV) for adults 60 and older who have discussed it with their health care provider. The vaccines, which will be available this fall, could save thousands of older-adult lives each year.
The United States Preventive Services Task Force (USPSTF) released new guidelines on screening asymptomatic adults for depression, suicide risk and anxiety—marking the first time the Task Force issued a recommendation specifically on screening for anxiety disorders among adults.
Now that we are reaching a point where the U.S. has an adequate supply of COVID-19 vaccines, officials must consider how to identify and reach older adults who remain unvaccinated, particularly those who want but have been unable to access a vaccine.